Substance dependence. Mental and behavioural disorders due to use of opioids
Conditions
Interventions
Intervention 1: Intervention group: The Intervention group will attend group therapy DM techniques based sessions for three weeks (6 sessions of one hour). In general, the treatment plan for this grou
Treatment - Other
Lifestyle
Intervention group: The Intervention group will attend group therapy DM techniques based sessions for three weeks (6 sessions of one hour). In general, the treatment plan for this group will be to at
Control group:The control group simultaneously (six one-hour sessions for 3 weeks) will continue Center’s usual care plan of the group in such a way that they will discuss issues such as the effectiv
Sponsors
Vice chancellor for research, Islamic Azad University of Torbat-e-Jam
Eligibility
Sex/Gender
Male
Age
33 Years to 57 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Substance dependence based on Diagnostic and Statistical Manual of Mental Disorders- 4th ed., text rev. (DSM-IV-TR); being male?; abling to write and read; lack a history of problematic mental disorders and physical diseases; not recieving intrudent pharmalogical and nonpharmalogical treatments and completing the agreement form. Exclusion criteria: To be absence for 1 session; to be delay up 10 min and not to do homwork for money sessions; to ignore the laws that members of group agreed upon such as confidentiality and dicipline; to indicate teramatically mental or physical problems intrudenting to research.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tendency towards taking drugs. Timepoint: Before and after the treatment. Method of measurement: Relaps Prediction Scale (RPS).;Probability of taking drugs. Timepoint: Before and after the treatment. Method of measurement: Relaps Prediction Scale (RPS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive beliefs. Timepoint: Before and after the treatment. Method of measurement: Meta Cognitions Questionnaire- Short Form (MCQ-30).;Negative beliefs. Timepoint: Before and after the treatment. Method of measurement: Meta Cognitions Questionnaire- Short Form (MCQ-30).;Need to control thoughts. Timepoint: Before and after the treatment. Method of measurement: Meta Cognitions Questionnaire- Short Form (MCQ-30).;Cognitive confidence. Timepoint: Before and after the treatment. Method of measurement: Meta Cognitions Questionnaire- Short Form (MCQ-30).;Cognitive self-consciousness. Timepoint: Before and after the treatment. Method of measurement: Meta Cognitions Questionnaire- Short Form (MCQ-30).;Metacognition. Timepoint: Before and after the treatment. Method of measurement: Meta Cognitions Questionnaire- Short Form (MCQ-30).;Depression. Timepoint: Before and after the treatment. Method of measurement: Beck Depression Inventory -2th ed. (BDI-11).;Anxiety. Timepoint: Before and after the treatment. Method of measurement: Beck Anxiety Inventory (BAI).;Client Satisfaction. Timepoint: After the treatment. Method of measurement: Client Satisfaction Questionnaire (CSQ).;Clinical Global Impressions. Timepoint: After the treatment. Method of measurement: Clinical Global Impressions (CGI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Shareh
Hakim Sabzevari University
Outcome results
None listed